Physician profile

Kousik Krishnan

Clinical Cardiac Electrophysiology · Naperville, IL

NPI 1225054505

$311,128.10

in general payments reported to CMS, 2019-2025

31 companies · $80K in 2025

The $80K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$68,233.97
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$32,250.00
Travel and Lodging$27,020.93
Food and Beverage$9,955.03
Honoraria$8,000.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biosense Webster, INC. $95,261.33 2019-2025 Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $57,225.93 2019-2025 Lifevest
Boston Scientific Corporation $44,380.19 2019-2025 Watchman Access System, Farapulse, Watchman Flx
Janssen Pharmaceuticals, INC $43,445.09 2019-2022
Abbott Laboratories $32,094.59 2019-2025 Aveir, Tacticath Ablation Catheter, Sensor Enabled, Ensite
Baylis Medical Company INC $6,641.57 2019-2021
Sanofi-Aventis U.S. LLC $6,111.51 2019-2023
Pfizer INC. $5,987.53 2019-2025
Medtronic, INC. $5,523.57 2021-2025 Pulseselect, Na, Aurora Ev-Icd Mri Surescan
E.R. Squibb & Sons, L.L.C. $3,703.50 2019-2025 Camzyos
Altathera Pharmaceuticals LLC $2,392.61 2025 Sotalol Hydrochloride
Cardiva Medical, INC. $2,127.62 2019-2025 Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f
Medical Device Business Services, INC. $2,004.75 2023-2024 Carto 3
Medtronic Vascular, INC. $1,378.73 2019-2020
Elutia, INC. $858.29 2019-2025 Ecm Patch,Pouch
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Zoll Medical Corporation $400.00 2020
Biotronik INC. $322.88 2019-2024
Novartis Pharmaceuticals Corporation $316.70 2021-2025
Atricure, INC. $213.03 2020-2025 Epi-Sense Guided Coagulation System With Visitrax
Itamar Medical INC $137.93 2024 Watchpatone
Cardiofocus, INC. $130.58 2022
Cvrx, INC. $105.78 2024 Barostim Neo System
Medtronic USA, INC. $97.88 2019
Philips North America LLC $96.76 2023-2024 (Ao0) Igt Devices Intracardiac
Siemens Medical Solutions USA, INC. $62.16 2024 Acuson Origin Diagnostic Ultrasound System
Ethicon US, LLC $40.13 2023 Vistaseal, Ethicon
Scpharmaceuticals INC. $26.78 2024
Amgen INC. $19.22 2025 Repatha
Adagio Medical, INC. $18.26 2022
Impulse Dynamics (USA) INC. $3.20 2025 Optimizer

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kousik Krishnan

$311,128.10

in general payments reported 2019-2025

Years
2019-2025
Top company
Biosense Webster, INC.
Context
The $80K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/328019/kousik-krishnan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.